Anna Fritsch

partner for a better patient journey in #oncology @roche with digital production experience #cancer #patientcentric #PROMs

[Alessio Cortellini @ACortelliniMD]

Great meeting this afternoon at @hug_ge in Geneve🇨🇭 hosted by @Alfdoc2, with @TelmaSequeiraMD and colleagues from across Switzerland, diving into the latest advances in #SCLC
Despite all the convoluted and chaotic steps in the field, we are finally seeing real progress!
Always inspiring to mix smart people with good vibes🌟
@CampusBioMedico @PoliclinCampus @ImperialSandC @IASLC

[Lung Cancer Europe @LungCancerEu]

New @IASLC data show smoking affects #lungcancer survival even within each stage.

People who currently or formerly smoked often had outcomes similar to never-smokers in the next higher stage.

Smoking may now be considered in the 10th TNM staging system.

https://t.co/LdrjBsBWF0

#LCSM

[International Lung Cancer Summit @LungSummit]

It’s time – ILCS25 has begun!

We’re excited to see many of you in Lausanne and connect with colleagues joining online.
Everything is ready for a smooth experience.

Should you have any questions or suggestions, our team is here to help ➡️ https://t.co/n1laH6mSMP

[Timothée Olivier, MD @Timothee_MD]

Congratulations @JLSandoval et al. for this study exploring biomarkers in ovarian cancer!
Very nice collaborative effort, well done 👍 👏#ASCO25
@hug_ge @institut_curie !

[Vivek Subbiah, MD @VivekSubbiah]

🚨Hot off the press! 🌟 We're thrilled to announce the publication of our article in the @ASCO Educational Handbook 👉"Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras." 🦓 just in time for AACR & ASCO meetings! Read it for FREE online now! @targetcancer @Dr_R_Kurzrock @CuglievanBranko @SarahCannonDocs
📚 #RareCancers #ClinicalTrials #ASCO25 #AACR25 @JCO_ASCO @ASCOPres @ConquerCancerFd @n8pennell @PBarataMD @hoperugo
LINK: https://t.co/m09lyTXC17

[Brandon Luu, MD @BrandonLuuMD]

A new twin study has strengthened the link between tattoos and cancer risk.

For tattoos larger than a palm:
🔺 137% higher risk of skin cancer (HR = 2.37)
🩸 173% higher risk of lymphoma (HR = 2.73)

Let’s break it down 🧵 1/11

[Brandon Luu, MD @BrandonLuuMD]

Lifestyle is a stronger predictor of aging and mortality than genetics.

A new Nature study of ~500,000 people found:
🎯 17% of mortality variation was linked to lifestyle (exposome).
🧬 <2% of was explained by genetics.

Here’s what you need to know 👇🧵 1/10

[Anna Fritsch @AnnaFritsch]

@Alfdoc2 @DOncologie @hug_ge great achievement 👏

[HUG @hug_ge]

Développez vos connaissances en #oncologie gastro-intestinale auprès d’expertes et d’experts suisses et internationaux. Vendredi 7 février, les HUG accueillent deux manifestations consacrées à cette spécialité: https://t.co/eJrvAsVU1J #ASCOGI #GI25 #cancer @DOncologie

[Tim Williams @t1mwilliams]

Hold on:

“Alert-based PRO monitoring led to a 29% reduction in mortality in the intervention group compared to the control group”

…. That’s pretty good, right?!

#NHS #cancer #PROMs #SABCS2024 @MyClinOutcomes

[İmdat Eroğlu @imdat_eroglu]

I am very excited to share that we will discuss precision oncology in lung cancer with the experts @Alfdoc2 , @UmbertoMalapel1 and Mafalda da Costa on 14th Nov.
I am grateful to @ESOncology for this chance.
Big thanks to my proffessors at @Gazi_Universite for their support

[José Sandoval @JLSandoval]

We were 9 strong at #ESMO24 from @hug_ge, @DOncologie, @UNIGEnews&amp; @Timothee_MD virtually. @MarieE_Gaignard presented her work in the poster session, and @Alfdoc2 will be presenting the #ESMO24 lung cancer highlights on Tuesday. Looking forward to what the future holds!

[Clinical Cancer Research @CCR_AACR]

Platinum-Based #Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade.
https://t.co/sZyjrwNCtZ

[Timothée Olivier, MD @Timothee_MD]

Heureux de participer au nouveau numéro dédié à l'oncologie de la @revmedsuisse avec mes collègues @DOncologie❗️

"Interpréter un essai randomisé en oncologie : éléments clés en clinique"

https://t.co/wrlHXq7Kdh pour le numéro complet!
+ ici : https://t.co/oLt0rRP4QQ 👇

[EASLnews @EASLnews]

The prevalence of Steatotic Liver Disease is staggering, affecting millions worldwide, and linked to t2 diabetes and obesity.

Collaboration is key in the fight against SLD. Through partnerships with health leaders, policymakers, and patient organisations, we're fostering a united front.
Together, let's make SLD visible on the global health agenda.

By uniting our efforts and advocating for change on occasions such as #WorldLiverDay, we can pave the way for healthier livers and healthier lives.

Read more: https://t.co/jVonB1OBDM

@WorldLiverDay

[soria @jsoriamd]

EGFR mutants are not a monolithic entity. In fact EGFR mutational status is heterogeneous and EGFR mutated cancers can be Dr Jekyll or Mr Hyde #AACR24 @marinagarassino

[EASLnews @EASLnews]

Chronic liver disease causes 1.8% of all deaths in Europe. Without policies to mitigate harmful alcohol consumption and obesity, that proportion will continue to increase.

Watch the next EASL Studio, presenting the results of the Hepahealth II Study aimed at preventing liver disease with policy measures!

Tune in tomorrow 18:00 CET and hear from Patrizia Burra, @Mariabutif, @HepatoEpi & @SagiZelber.

📺https://t.co/BOezcUFEzc

#LiverTwitter @EASLEUAffairs

[Oncology Division - Geneva University Hospital @DOncologie]

Online now - Engineered dendritic cells for cancer immunotherapy make the cover @NatureCancer.
Congratulations to Prof. @MiglioriniDenis , Mathias Heikenwälder @CancerInflam, and Michele de Palma's Labs @UNIGEnews @DKFZ @EPFL @FondationIsrec
👉 https://t.co/3B5v21lViY

[HUG @hug_ge]

Les HUG ont organisé la première journée de dépistage de la fibrose du foie. Le Dr Nicolas Goossens parle de cette maladie souvent méconnue mais pouvant entraîner des pathologies graves : https://t.co/LiC9pvgzLN @NicoGooss #dépistage #foie #santé

[Oncology UNIL CHUV @OncoUNILCHUV]

🟣World Pancreatic Cancer Day🟣 16th of November
#panCan #PancreaticCancer @PanCAN